GlassScriptPhysician profile
John A Hartman
NPI 1104238666
$1,466.90
in general payments reported to CMS, 2019-2025
21 companies · $20.02 in 2025
The $20.02 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $602 · 2020: $485 · 2021: $280 · 2022: $51.73 · 2023: $28.34 · 2025: $20.02.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $48.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $48.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $359.54 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $167.85 | 2019-2021 | |
| Novo Nordisk INC | $125.10 | 2019-2021 | |
| Pfizer INC. | $120.16 | 2019-2021 | |
| Astellas Pharma US INC | $99.99 | 2019 | |
| Lilly USA, LLC | $84.39 | 2019-2021 | |
| Relievant Medsystems, INC. | $80.07 | 2022-2023 | Intracept |
| Allergan, INC. | $68.60 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $50.92 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $50.75 | 2019 | |
| Amarin Pharma, INC. | $42.72 | 2019-2020 | |
| Eisai INC. | $39.56 | 2020-2021 | |
| Glaxosmithkline, LLC. | $28.65 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.60 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.99 | 2021 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $20.02 | 2025 | Flowtriever |
| Boston Scientific Corporation | $15.85 | 2019 | |
| Radius Health, INC. | $15.58 | 2020 | |
| Esperion Therapeutics, INC. | $15.31 | 2021 | |
| Genentech USA, INC. | $14.96 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.29 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hartman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.